GDF2 and pulmonary arterial hypertension: In contrast, no efficacy in PAH parameters was observed with WT BMP9 despite a sustained dose-dependent increase in BMPR2-SMAD1/5/8 regulated gene expression, indicating engagement of the BMPR2 signaling pathway.